Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Judith A. Seidel(Beiersdorf (Germany)), Kenji Kabashima(Kyoto University)
Frontiers in Oncology
March 28, 2018
Cited by 1,331


Related Papers